SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

Share Price is delayed by 15 minutes
Get Live Data
0.53    -0.002 (-0.38%)
Bid:
0.51
Ask:
0.528
Spread: 0.018 (3.529%)
Market Cap: $308.10m
IDHC Live PriceLast checked at - London Stock Exchange

Intraday Int Diag Hld Share Chart

Stabilisation Notice

6 May 2015 07:20

RNS Number : 3028M
Deutsche Bank AG London
06 May 2015
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Integrated Diagnostics Holdings plc (the "Company")

Stabilisation Notice

6 May 2015

Deutsche Bank AG, London Branch (contact: Paul Huysmans, telephone: 020 7547 4836) hereby gives notice that the Stabilising Manager named below and its affiliates may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

The securities:

Issuer:

Integrated Diagnostics Holdings plc

Selling Shareholder:

Integrated Diagnostics Group Limited and HENA Holdings Limited (together, the "Selling Shareholders").

Securities:

Ordinary shares of $1.00 each ("ORDs") of the Issuer (ISIN: JE00BV9H9G76)

Offering size:

$ 290,217,394.40

Offer price:

$ 4.45

Stabilisation:

Stabilising Manager:

Deutsche Bank AG, London Branch

Winchester House

1 Great Winchester Street

London EC2N 2DB

United Kingdom

Stabilisation period expected to start on:

6 May 2015

Stabilisation period expected to end no later than:

4 June 2015

Maximum size of over-allotment facility:

9,782,608 ORDs

Over-allotment Option:

Terms:

The Selling Shareholders has granted Deutsche Bank AG, London Branch, in its capacity as stabilisation manager and for the account of the underwriters, the option to acquire up to an additional 9,782,608 ORDs at the Offer price.

Duration:

This option may be executed at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAEAKSKEFESEEF
Date   Source Headline
20th May 20262:05 pmRNSReplacement - 1st Quarter Results
20th May 20267:00 amRNS1st Quarter Results
19th May 20265:09 pmRNSResult of AGM
30th Apr 202612:39 pmRNSReplacement - Holding(s) in Company
23rd Apr 20261:06 pmRNSAnnual Financial Report & Notice of AGM
17th Apr 20267:00 amRNSFinal Results
8th Apr 20265:50 pmRNSHolding(s) in Company
8th Apr 20265:49 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNS3rd Quarter Results
7th Nov 20257:00 amRNSNotice of Results
2nd Sep 20257:00 amRNSHalf-year Report
29th Aug 202511:55 amRNSNotice of Results
20th Jun 20257:00 amRNSIDH Strengthens Egyptian Radiology portfolio
28th May 20257:00 amRNS1st Quarter Results
27th May 20255:00 pmRNSResult of AGM
22nd May 20257:00 amRNSNotice of Results
24th Apr 20253:30 pmRNSAnnual Financial Report & Notice of AGM
17th Apr 20257:00 amRNSFinal Results
10th Apr 20254:41 pmRNSNotice of Results
9th Dec 202410:59 amRNSIDH INCREASES STAKE IN BIOLAB KSA
14th Nov 20247:00 amRNS3rd Quarter Results
11th Nov 202411:29 amRNSNotice of Results
8th Oct 20245:21 pmRNSCancellation of Treasury Shares
1st Oct 20249:00 amRNSTotal Voting Rights
18th Sep 20244:14 pmRNSCompletion of Treasury Shares Removal Process
6th Sep 20247:00 amRNSUpdate on Treasury Shares Removal Process
5th Sep 20247:00 amRNSCompletion of EGX Delisting
28th Aug 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSEGX Delisting – buyback under EGX's OPR
23rd Aug 20241:30 pmRNSNotice of Results
13th Aug 20247:00 amRNSEGX Delisting – timeline under EGX's OPR
18th Jul 20243:45 pmRNSResults of Extraordinary General Meeting
1st Jul 20243:40 pmRNSPublication of Circular and Notice of EGM
27th Jun 20247:00 amRNSIDH's proposed revised Delisting Buyback Price
12th Jun 20243:35 pmRNSResults of Extraordinary General Meeting
30th May 20247:00 amRNS1ST QUARTER RESULTS
29th May 20243:44 pmRNSResult of AGM
28th May 202410:42 amRNSNotice of Results
24th May 20244:16 pmRNSPublication of Circular and Notice of EGM
16th May 20247:00 amRNSIDH proposing to delist its shares from the EGX
30th Apr 20242:13 pmRNSNotice of AGM
4th Apr 20241:55 pmRNSAnnual Financial Report
28th Mar 20247:00 amRNSFinal Results
26th Mar 20249:15 amRNSNotice of Results
18th Jan 20244:03 pmRNSIDH appoints Group CFO, VP and Board Member
16th Nov 20237:00 amRNS3rd Quarter Results
25th Oct 20237:00 amRNSIDH CEO increases stake in the Company
17th Oct 20231:56 pmRNSDirector/PDMR Shareholding
16th Oct 202312:26 pmRNSDirector/PDMR Shareholding
13th Oct 20232:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.